AI-Designed Custom Biocatalysts

inquiry

Creative Enzymes combines machine learning with directed evolution to accelerate enzyme engineering while reducing screening burden. Our platform replaces random mutagenesis with intelligent library design, predicting high-impact mutations and prioritizing variants before they reach the bench. The result is faster convergence on optimized biocatalysts with fewer experimental cycles and lower resource consumption.

Why Custom Biocatalysts?

Natural enzymes evolved for biological functions, not industrial processes. This evolutionary mismatch creates persistent limitations:

Incompatibility with Industrial Conditions

Natural enzymes operate at physiological temperature, pH, and ionic strength. Manufacturing conditions frequently demand elevated temperatures, organic co-solvents, or extreme pH that denature or inactivate wild-type enzymes.

Substrate Constraints

Evolution optimizes enzymes for metabolites present in the host organism. Industrial substrates are often structurally distinct, larger, or more hydrophobic than natural counterparts, resulting in poor binding or negligible turnover.

Stability Limitations

Operational stability under process conditions—continuous reactor operation, freeze-thaw cycles, or long-term storage—exceeds the evolutionary pressure on most natural enzymes. Rapid inactivation inflates catalyst cost and complicates process design.

Custom biocatalyst design addresses these mismatches by specifying the target application as the design objective from the outset. The enzyme is engineered for the process, not the process adapted to the enzyme.

AI-Assisted Biocatalyst Design Platform

Not just algorithms—a complete toolkit spanning sequence intelligence to wet lab validation.

Substrate-Oriented Design

Active-site geometry and binding pocket properties are specified to accommodate target substrates. Substrate analogs are modeled within the pocket to identify steric constraints, electronic complementarity, and optimal orientation for catalysis.

Stability Engineering

Thermal tolerance, organic solvent resistance, and aggregation propensity are predicted and optimized through surface charge redistribution, core packing improvement, and loop rigidification. Stability is not an afterthought—it is co-optimized with activity.

Process Adaptability Optimization

Enzymes are designed for compatibility with manufacturing constraints: high substrate and product concentrations, cofactor regeneration systems, immobilization chemistries, and purification protocols. Process parameters inform design decisions.

Catalytic Efficiency Enhancement

Turnover rates and substrate affinities are improved through transition-state stabilization, accelerated product release, and optimized proton relay networks. Efficiency targets are calibrated to process economics.

Multi-Parameter Optimization

No single property dominates. AI models balance competing objectives—activity versus stability, specificity versus promiscuity, expression yield versus folding complexity—through Pareto optimization. The output is a set of designs representing optimal trade-offs for client evaluation.

Customized Engineering Workflow

1. Application Requirement: The target process is characterized: reaction type, substrate and product structures, operating conditions, purity requirements, and economic constraints. These specifications define the optimization landscape.

2. Target Property Analysis: Critical properties are ranked by process impact. Activity, stability, specificity, and expression are quantified as optimization targets with defined thresholds and relative priorities.

3. AI-Guided Design: Computational models generate candidate sequences predicted to satisfy the target property profile. Designs span a range of architectural solutions, from modified natural scaffolds to de novo generated sequences.

4. Candidate Optimization: Top-ranked candidates are refined through iterative modeling: active-site adjustments, stability predictions, and expression optimization. The output is a focused set of variants for experimental evaluation.

5. Validation & Iteration: Designed variants are expressed, purified, and characterized under process-relevant conditions. Results validate or refute predictions, and successful designs proceed to scale-up. Underperforming designs inform model refinement for subsequent iterations.

Application Areas

Our AI-guided custom biocatalyst platform supports diverse research and development objectives:

Pharmaceutical Synthesis

Enantioselective biocatalysts for chiral intermediate production, reducing reliance on stoichiometric reagents and chromatographic resolution.

Green Chemistry

Solvent-tolerant, cofactor-efficient enzymes that replace hazardous chemical catalysts with aqueous, ambient-pressure biotransformations.

Food Biotechnology

Process-stable enzymes for ingredient modification, shelf-life extension, and nutritional enhancement under food-grade conditions.

Specialty Chemicals

High-selectivity biocatalysts for complex molecule synthesis where chemical methods lack regio- or stereocontrol.

Related Biocatalyst Development Services

Creative Enzymes also offers industrial biocatalyst development services, including enzyme optimization, process compatibility testing, fermentation development, catalytic performance evaluation, and industrial enzyme characterization to support customized biocatalyst engineering projects.

Example Use Cases

Pinal: Language-Guided De Novo Protein Design

Figure 1: Overview of Pinal. (Dai et al., 2024)

This study introduces Pinal, a probabilistic framework for de novo protein design that uses natural language instructions to guide protein generation. Unlike conventional deep learning approaches that directly generate sequences, Pinal employs a two-stage strategy: first generating protein structures from textual descriptions, then designing sequences conditioned on both the structure and language input. By focusing on the smaller structural search space, the method improves design efficiency and diversity. Experimental results showed that Pinal outperformed existing protein design models, including ESM3, and successfully generalized to novel protein structures outside its training distribution. The approach demonstrates the growing potential of language-guided AI systems for flexible and controllable protein engineering.

gcWGAN for Novel Protein Fold Design

Figure 2: De novo protein design for novel folds using guided conditional wasserstein generative adversarial networks. (Karimi et al., 2020)

This study presents gcWGAN, a semi-supervised deep generative framework for designing protein sequences that adopt arbitrary and potentially novel structural folds. Built on conditional Wasserstein generative adversarial networks, the method integrates a low-dimensional fold representation, an ultrafast sequence-to-fold predictor, and semi-supervised learning using sequence data with or without structural annotations. Compared with competing models such as conditional variational autoencoders, gcWGAN generated more successful and diverse protein designs across 100 unseen folds, covering 3.5 times more target structures. The generated sequences were predicted to be physically and biologically realistic and could also enhance traditional de novo design methods such as RosettaDesign by providing optimized design seeds and search spaces.

Why Creative Enzymes

Our integrated approach delivers measurable advantages over conventional service models:

Customized Support

Each project begins with detailed application analysis. Design targets are defined collaboratively, not imposed from standard templates.

Integrated Workflow

Computational design, gene synthesis, expression, purification, and characterization operate as a unified pipeline with single-point project management.

Wet Lab Validation

All designs are experimentally validated under conditions matching intended application. Predictions without experimental confirmation are not delivered as final results.

FAQs

Q: Can you design enzymes for specific substrates?

A: Yes. Substrate structure is a primary design input. We model substrate binding geometry, identify compatible catalytic mechanisms, and engineer active-site environments tailored to target molecules. Both natural and non-natural substrates are accommodated.
Q: Do you support industrial process optimization?

A: Yes. Process parameters—temperature, pH, solvent composition, substrate concentration, cofactor requirements—are specified as design constraints from project initiation. The output is a biocatalyst optimized for your process, not a generic enzyme requiring process adaptation.
Q: Can custom biocatalysts be experimentally validated?

A: Yes. Experimental validation is integral to our service, not optional. All designed candidates are expressed and characterized for the target properties. Validation data are delivered with the final biocatalyst, and unsuccessful designs are analyzed to improve subsequent iterations.
Q: What is the typical project timeline?

A: 4–6 months from requirement definition to validated biocatalyst for moderate complexity targets. Novel activities or extreme property combinations may extend to 8–10 months. Expedited timelines are available for prioritized projects.
Q: Do you handle scale-up and manufacturing?

A: We provide expression optimization and small-scale purification for validation. Scale-up to manufacturing quantities and technology transfer to production facilities are supported through partner networks or client-specified CMOs.
Q: Who owns the intellectual property?

A: All designed sequences, validation data, and associated know-how are client property. Creative Enzymes operates under standard confidentiality and IP assignment agreements.

References:

Dai F, You S, Zhu Y, et al. Toward de novo protein design from natural language. Preprint posted online August 2, 2024. doi:10.1101/2024.08.01.606258
Karimi M, Zhu S, Cao Y, Shen Y. De novo protein design for novel folds using guided conditional wasserstein generative adversarial networks. J Chem Inf Model. 2020;60(12):5667-5681. doi:10.1021/acs.jcim.0c00593

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested *

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry